Ryan Nipp to Prognosis
This is a "connection" page, showing publications Ryan Nipp has written about Prognosis.
Connection Strength
1.298
-
Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer. J Natl Compr Canc Netw. 2020 06; 18(6):747-754.
Score: 0.148
-
Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer. Ann Oncol. 2019 02 01; 30(2):274-280.
Score: 0.135
-
The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer. 2017 Dec 01; 123(23):4720-4727.
Score: 0.124
-
Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer. Oncologist. 2018 01; 23(1):97-104.
Score: 0.123
-
Coping and Prognostic Awareness in Patients With Advanced Cancer. J Clin Oncol. 2017 Aug 01; 35(22):2551-2557.
Score: 0.120
-
Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment. Pancreas. 2017 02; 46(2):183-189.
Score: 0.118
-
CD38 variation as a prognostic factor in chronic lymphocytic leukemia. Leuk Lymphoma. 2014 Jan; 55(1):191-4.
Score: 0.091
-
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer. JCO Oncol Pract. 2021 12; 17(12):e1846-e1855.
Score: 0.040
-
Caregiver-Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life. Oncologist. 2021 04; 26(4):310-317.
Score: 0.039
-
Prognostic Awareness in Caregivers of Patients with Incurable Cancer. J Palliat Med. 2021 04; 24(4):561-569.
Score: 0.038
-
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors. Cancer. 2020 05 15; 126(10):2288-2295.
Score: 0.036
-
Potentially burdensome end-of-life transitions among nursing home residents with poor-prognosis cancer. Cancer. 2020 03 15; 126(6):1322-1329.
Score: 0.036
-
Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Ann Surg. 2019 04; 269(4):733-740.
Score: 0.034
-
Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Oncologist. 2019 07; 24(7):945-954.
Score: 0.034
-
Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 03; 14(3):547-552.
Score: 0.033
-
Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2018 07; 41(7):656-661.
Score: 0.032
-
Hospice utilization in patients with malignant gliomas. Neuro Oncol. 2018 03 27; 20(4):538-545.
Score: 0.032
-
The Tipping Point: Key Oncologic Imaging Findings Resulting in Critical Changes in the Management of Malignant Tumors of the Gastrointestinal Tract. Curr Probl Diagn Radiol. 2019 Jan; 48(1):61-74.
Score: 0.032
-
Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer. Dis Colon Rectum. 2016 Mar; 59(3):187-93.
Score: 0.028
-
Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer. J Pain Symptom Manage. 2015 Apr; 49(4):680-9.
Score: 0.025